Medicilon-MPI Preclinical Research (Shanghai) LLC Offers US FDA GLP Services

Published: Dec 08, 2009

SHANGHAI, China--(BUSINESS WIRE)--Medicilon/MPI Preclinical Research-Shanghai has recently expanded their service offerings to provide Sponsors with the ability to conduct studies that meet the US FDA Good Laboratory Practice (GLP) regulations, at their Chuansha facility in Shanghai China.

Back to news